Saurabh Mukewar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Saurabh Mukewar has a total of 203 co-authors. Here are the top co-authors by number of shared publications:
Shrikant Mukewar
9 shared publicationsBhushan Bhaware
8 shared publications- Ayush Sharma
Department of Spine Surgery, Dr. Babasaheb Ambedkar Memorial Hospital, Mumbai, Maharashtra, India
4 shared publications - Akshay Kulkarni
Midas Multi-Speciality Hospital, Nagpur, Maharashtra, India
3 shared publications Atul Gawande
Department of Gastroenterology, Midas Multi-Specialty Hospital, Nagpur, India
3 shared publications- Abraham Koshy
Department of Gastroenterology, VPS Lakeshore Hospital, Kochi, India
2 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 15 (4) , 324-325
EUS-guided hepatico-gastrostomy followed by antegrade digital cholangioscopy and laser lithotripsy for a large biliary stone in surgically altered anatomy (with video)
Was not provided for this article.
- 1 July 2026
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 15 (4) , 324-325
Open AccessEUS-guided hepatico-gastrostomy followed by antegrade digital cholangioscopy and laser lithotripsy for a large biliary stone in surgically altered anatomy (with video)
Was not provided for this article.
- Open Access
- 8 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 01) , E436-E437
Targeted endoscopic ultrasound-guided vascular angiotherapy for refractory upper gastrointestinal bleeding due to an aberrant collateral vessel
A 21-year-old man with no significant past medical history presented with a 5-month history of recurrent hematemesis, including several episodes of massive upper gastrointestinal bleeding. He required transfusion of 10 units of packed red blood cells and underwent three upper gastrointestinal endoscopies during this period. All examinations demonstrated a persistent gastric fundal protuberance with inflammatory changes on biopsies. The lesion was suspected to be a gastrointestinal stromal tumor and later misinterpreted as an isolated gastric varix, leading to cyanoacrylate injection without clinical benefits. An externally performed endoscopic ultrasound (EUS) excluded both diagnoses but failed to identify the source of bleeding. The patient was subsequently referred to our center for further evaluation. A computed tomographic scan revealed segmental narrowing with partial thrombosis of the splenic vein, marked dilatation of collateral vessels at the splenic hilum, and splenomegaly, without any active bleeding ([Fig. 1]). Upper gastrointestinal endoscopy demonstrated a mucosal protuberance in the proximal gastric body along the greater curvature, with normal surrounding mucosa ([Fig. 2]). Radial EUS identified an isoechoic lesion measuring 15 × 13 mm, predominantly confined to the mucosal layer. A linear anechoic structure traversing the muscularis propria toward the lesion was visualized ([Fig. 3]). Power Doppler imaging confirmed the active blood flow within this vessel, measuring approximately 1.2 mm in diameter. These findings were consistent with an aberrant collateral vessel arising from splenic vein thrombosis. Given the high likelihood that this vessel was responsible for the recurrent bleeding, EUS-guided vascular therapy was performed (using a 19G EUS FNA needle). One cc of cyanoacrylate glue was successfully injected into the vessel under EUS guidance, resulting in immediate obliteration and confirmed the absence of Doppler flow ([Video 1]). The patient experienced no further episodes of gastrointestinal bleeding, and hemoglobin levels remained stable during 3 months of follow-up. This case highlights EUS-guided angiotherapy [1] [2] as a rescue therapy where no other management options exist. Endoscopy_UCTN_Code_CCL_1AB_2AD_3AZ Endoscopy_UCTN_Code_TTT_1AS_2AL Article published online: 25 March 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 8 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 01) , E436-E437
Open AccessTargeted endoscopic ultrasound-guided vascular angiotherapy for refractory upper gastrointestinal bleeding due to an aberrant collateral vessel
A 21-year-old man with no significant past medical history presented with a 5-month history of recurrent hematemesis, including several episodes of massive upper gastrointestinal bleeding. He required transfusion of 10 units of packed red blood cells and underwent three upper gastrointestinal endoscopies during this period. All examinations demonstrated a persistent gastric fundal protuberance with inflammatory changes on biopsies. The lesion was suspected to be a gastrointestinal stromal tumor and later misinterpreted as an isolated gastric varix, leading to cyanoacrylate injection without clinical benefits. An externally performed endoscopic ultrasound (EUS) excluded both diagnoses but failed to identify the source of bleeding. The patient was subsequently referred to our center for further evaluation. A computed tomographic scan revealed segmental narrowing with partial thrombosis of the splenic vein, marked dilatation of collateral vessels at the splenic hilum, and splenomegaly, without any active bleeding ([Fig. 1]). Upper gastrointestinal endoscopy demonstrated a mucosal protuberance in the proximal gastric body along the greater curvature, with normal surrounding mucosa ([Fig. 2]). Radial EUS identified an isoechoic lesion measuring 15 × 13 mm, predominantly confined to the mucosal layer. A linear anechoic structure traversing the muscularis propria toward the lesion was visualized ([Fig. 3]). Power Doppler imaging confirmed the active blood flow within this vessel, measuring approximately 1.2 mm in diameter. These findings were consistent with an aberrant collateral vessel arising from splenic vein thrombosis. Given the high likelihood that this vessel was responsible for the recurrent bleeding, EUS-guided vascular therapy was performed (using a 19G EUS FNA needle). One cc of cyanoacrylate glue was successfully injected into the vessel under EUS guidance, resulting in immediate obliteration and confirmed the absence of Doppler flow ([Video 1]). The patient experienced no further episodes of gastrointestinal bleeding, and hemoglobin levels remained stable during 3 months of follow-up. This case highlights EUS-guided angiotherapy [1] [2] as a rescue therapy where no other management options exist. Endoscopy_UCTN_Code_CCL_1AB_2AD_3AZ Endoscopy_UCTN_Code_TTT_1AS_2AL Article published online: 25 March 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 25 October 2025
- Published by Springer Nature in Hepatology International
- Vol. 20 (1) , 149-162
Diabetes mellitus is linked to higher mortality in alcohol-related acute-on-chronic liver failure
Background Acute-on-chronic liver failure (ACLF) is a rapidly progressive syndrome marked by high short-term mortality. While diabetes mellitus (DM) is known to worsen liver-related outcomes, its specific impact on alcohol-related ACLF (ALD-ACLF) remains underexplored. This study aimed to assess the prognostic impact of DM on 90-day outcomes in ALD-ACLF using data from the APASL ACLF Research Consortium (AARC) database. Methods This observational study involved data from 5612 ACLF patients with documented 90-day outcomes. We identified 2096 patients with ALD-ACLF precipitated by alcoholic hepatitis. Patients with non-ALD etiologies, mixed etiologies, or non-alcoholic precipitants were excluded. Diabetic and non-diabetic patients were compared using 1:2 propensity score matching based on key baseline covariates. Survival outcomes were assessed using Kaplan–Meier analysis and multivariable Cox regression. Results After matching, 109 diabetic patients were compared with 218 well-matched non-diabetic controls. Diabetic patients had significantly lower overall survival (32 vs. 57%) and transplant-free survival (31 vs. 50%) compared to non-diabetics (log-rank p < 0.001). On multivariable Cox regression, DM was independently associated with increased 90-day mortality (HR 1.739, 95% CI 1.262–2.395, p < 0.001), along with elevated serum lactate (HR 1.187 per mmol/L, p < 0.001) and creatinine (HR 1.267 per mg/dL, p < 0.001). Conclusion Diabetes mellitus is a significant independent predictor of mortality in patients with ALD-ACLF. These findings highlight the need for early identification and integrated management of diabetes in ACLF care pathways to improve clinical outcomes.
- 25 October 2025
- Published by Springer Nature in Hepatology International
- Vol. 20 (1) , 149-162
Diabetes mellitus is linked to higher mortality in alcohol-related acute-on-chronic liver failure
Background Acute-on-chronic liver failure (ACLF) is a rapidly progressive syndrome marked by high short-term mortality. While diabetes mellitus (DM) is known to worsen liver-related outcomes, its specific impact on alcohol-related ACLF (ALD-ACLF) remains underexplored. This study aimed to assess the prognostic impact of DM on 90-day outcomes in ALD-ACLF using data from the APASL ACLF Research Consortium (AARC) database. Methods This observational study involved data from 5612 ACLF patients with documented 90-day outcomes. We identified 2096 patients with ALD-ACLF precipitated by alcoholic hepatitis. Patients with non-ALD etiologies, mixed etiologies, or non-alcoholic precipitants were excluded. Diabetic and non-diabetic patients were compared using 1:2 propensity score matching based on key baseline covariates. Survival outcomes were assessed using Kaplan–Meier analysis and multivariable Cox regression. Results After matching, 109 diabetic patients were compared with 218 well-matched non-diabetic controls. Diabetic patients had significantly lower overall survival (32 vs. 57%) and transplant-free survival (31 vs. 50%) compared to non-diabetics (log-rank p < 0.001). On multivariable Cox regression, DM was independently associated with increased 90-day mortality (HR 1.739, 95% CI 1.262–2.395, p < 0.001), along with elevated serum lactate (HR 1.187 per mmol/L, p < 0.001) and creatinine (HR 1.267 per mg/dL, p < 0.001). Conclusion Diabetes mellitus is a significant independent predictor of mortality in patients with ALD-ACLF. These findings highlight the need for early identification and integrated management of diabetes in ACLF care pathways to improve clinical outcomes.
- Open Access
- 27 September 2024
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 15 (03) , 192-194
Endoscopic Ultrasound-Guided Management of an Esophageal Duplication Cyst
A 37-year-old female presented with dysphagia to solids and epigastric pain for 2 months. She denied any history of chest pain, regurgitation, or vomiting. Baseline investigations were unremarkable. An upper gastrointestinal endoscopy (UGIE) showed a globular swelling causing external compression of the lower third of the esophagus ([Fig. 1]). Possibilities of an abscess, a retroperitoneal tumor (sarcoma or a lipoma), were considered. She did not have any localizing symptoms of a primary malignancy; hence, metastasis was an unlikely differential. Endoscopic ultrasound (EUS) showed a cyst (3 × 2 cm) with hypoechoic contents and a multilayered wall, compressing the wall of the esophagus ([Video 1]). The mural layers of the cyst were contiguous with the esophageal wall, and it was an intramural cyst. Contrast-enhanced computed tomography of thorax showed a hypodense mediastinal mass abutting the lower esophagus ([Fig. 2A] and [B]). A diagnosis of duplication cyst was made. The patient declined surgery; hence, endoscopic management was planned. Intravenous ceftriaxone (1 g) was prophylactically administered before the procedure to prevent infection ([Video 1]). Under EUS guidance, a 19G fine-needle aspiration needle (Boston Scientific, Pennsylvania, United States) was used to puncture the cyst wall and pass a 0.035-inch guidewire into the cavity. Triangular tip knife (Olympus, Tokyo, Japan) was used to make a vertical incision on the adjacent esophageal wall; brownish fluid was seen exuding from the cyst. Biopsies were taken from the cyst wall, and the edges of the incision were clipped to avoid recurrence. Video 1 The patient recovered well; there was no pain or fever during the hospital stay. The leucocyte counts remained normal. Her dysphagia was completely relieved on follow-up at 2 weeks. The biopsies showed stratified squamous epithelium, confirming the diagnosis ([Fig. 3A]). On the follow-up visit, 3 months later, the repeat UGIE showed a simple diverticulum ([Fig. 3B]). Duplication cysts are uncommon; the previous literature predominantly describes surgical management.[1] Few cases report endoscopic fenestration.[2] [3] While EUS has been used for diagnosis,[4] there are concerns regarding infectious complications with needle aspiration.[1] Only one case of EUS-guided fenestration has been described so far.[5] EUS may alter the future of this intervention as it provides direct visualization of the cyst cavity, allows guided puncture of the cyst wall and tissue acquisition in case of suspicion of an alternate diagnosis. The manuscript has been submitted solely to this journal. Permission was obtained from all coauthors before submitting this article. No third-party material was reprinted, hence no permission was taken. The manuscript has not been invited. Article published online: 27 September 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- 27 September 2024
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 15 (03) , 192-194
Open AccessEndoscopic Ultrasound-Guided Management of an Esophageal Duplication Cyst
A 37-year-old female presented with dysphagia to solids and epigastric pain for 2 months. She denied any history of chest pain, regurgitation, or vomiting. Baseline investigations were unremarkable. An upper gastrointestinal endoscopy (UGIE) showed a globular swelling causing external compression of the lower third of the esophagus ([Fig. 1]). Possibilities of an abscess, a retroperitoneal tumor (sarcoma or a lipoma), were considered. She did not have any localizing symptoms of a primary malignancy; hence, metastasis was an unlikely differential. Endoscopic ultrasound (EUS) showed a cyst (3 × 2 cm) with hypoechoic contents and a multilayered wall, compressing the wall of the esophagus ([Video 1]). The mural layers of the cyst were contiguous with the esophageal wall, and it was an intramural cyst. Contrast-enhanced computed tomography of thorax showed a hypodense mediastinal mass abutting the lower esophagus ([Fig. 2A] and [B]). A diagnosis of duplication cyst was made. The patient declined surgery; hence, endoscopic management was planned. Intravenous ceftriaxone (1 g) was prophylactically administered before the procedure to prevent infection ([Video 1]). Under EUS guidance, a 19G fine-needle aspiration needle (Boston Scientific, Pennsylvania, United States) was used to puncture the cyst wall and pass a 0.035-inch guidewire into the cavity. Triangular tip knife (Olympus, Tokyo, Japan) was used to make a vertical incision on the adjacent esophageal wall; brownish fluid was seen exuding from the cyst. Biopsies were taken from the cyst wall, and the edges of the incision were clipped to avoid recurrence. Video 1 The patient recovered well; there was no pain or fever during the hospital stay. The leucocyte counts remained normal. Her dysphagia was completely relieved on follow-up at 2 weeks. The biopsies showed stratified squamous epithelium, confirming the diagnosis ([Fig. 3A]). On the follow-up visit, 3 months later, the repeat UGIE showed a simple diverticulum ([Fig. 3B]). Duplication cysts are uncommon; the previous literature predominantly describes surgical management.[1] Few cases report endoscopic fenestration.[2] [3] While EUS has been used for diagnosis,[4] there are concerns regarding infectious complications with needle aspiration.[1] Only one case of EUS-guided fenestration has been described so far.[5] EUS may alter the future of this intervention as it provides direct visualization of the cyst cavity, allows guided puncture of the cyst wall and tissue acquisition in case of suspicion of an alternate diagnosis. The manuscript has been submitted solely to this journal. Permission was obtained from all coauthors before submitting this article. No third-party material was reprinted, hence no permission was taken. The manuscript has not been invited. Article published online: 27 September 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- 17 July 2024
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 120 (4) , 816-826
Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in Metabolic Dysfunction Associated Fatty Liver Disease–Related Acute-on-Chronic Liver Failure
INTRODUCTION: The prevalence of metabolic dysfunction–associated fatty liver disease (MAFLD) and its complication, MAFLD-related acute-on-chronic liver failure (MAFLD-ACLF), is rising. Yet, factors determining patient outcomes in MAFLD-ACLF remain understudied. METHODS: Patients with MAFLD-ACLF were recruited from the Asian Pacific Association for the Study of the Liver-ACLF Research Consortium (AARC registry). The diagnosis of MAFLD-ACLF was made when the treating unit had identified the etiology of chronic liver disease as MAFLD (or previous nomenclature such as non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, or non-alcoholic steatohepatitis-cirrhosis). Patients with coexisting other etiologies of chronic liver disease (such as alcohol, hepatitis B virus, hepatitis C virus, etc.) were excluded. Data were randomly split into derivation (n = 258) and validation (n = 111) cohorts at a 70:30 ratio. The primary outcome was 90-day mortality. Only the baseline clinical, laboratory features and severity scores were considered. RESULTS: The derivation group had 258 patients; 60% were male, with a mean age of 53. Diabetes was noted in 27% and hypertension in 29%. The dominant precipitants included viral hepatitis (hepatitis A virus and hepatitis E virus, 32%), drug-induced injury (drug-induced liver injury, 29%), and sepsis (23%). Model for End-Stage Liver Disease-Sodium (MELD-Na) and AARC scores on admission averaged 32 ± 6 and 10.4 ± 1.9. At 90 days, 51% survived. Nonviral precipitant, diabetes, bilirubin, international normalized ratio, and encephalopathy were independent factors influencing mortality. Adding diabetes and precipitant to MELD-Na and AARC scores, the novel MAFLD-MELD-Na score (+12 for diabetes, +12 for nonviral precipitant), and MAFLD-AARC score (+5 for each) were formed. These outperformed the standard scores in both cohorts. DISCUSSION: Almost half of patients with MAFLD-ACLF die within 90 days. Diabetes and nonviral precipitants such as drug-induced liver injury and sepsis lead to adverse outcomes. The new MAFLD-MELD-Na and MAFLD-AARC scores provide reliable 90-day mortality predictions for patients with MAFLD-ACLF.
- 17 July 2024
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 120 (4) , 816-826
Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in Metabolic Dysfunction Associated Fatty Liver Disease–Related Acute-on-Chronic Liver Failure
INTRODUCTION: The prevalence of metabolic dysfunction–associated fatty liver disease (MAFLD) and its complication, MAFLD-related acute-on-chronic liver failure (MAFLD-ACLF), is rising. Yet, factors determining patient outcomes in MAFLD-ACLF remain understudied. METHODS: Patients with MAFLD-ACLF were recruited from the Asian Pacific Association for the Study of the Liver-ACLF Research Consortium (AARC registry). The diagnosis of MAFLD-ACLF was made when the treating unit had identified the etiology of chronic liver disease as MAFLD (or previous nomenclature such as non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, or non-alcoholic steatohepatitis-cirrhosis). Patients with coexisting other etiologies of chronic liver disease (such as alcohol, hepatitis B virus, hepatitis C virus, etc.) were excluded. Data were randomly split into derivation (n = 258) and validation (n = 111) cohorts at a 70:30 ratio. The primary outcome was 90-day mortality. Only the baseline clinical, laboratory features and severity scores were considered. RESULTS: The derivation group had 258 patients; 60% were male, with a mean age of 53. Diabetes was noted in 27% and hypertension in 29%. The dominant precipitants included viral hepatitis (hepatitis A virus and hepatitis E virus, 32%), drug-induced injury (drug-induced liver injury, 29%), and sepsis (23%). Model for End-Stage Liver Disease-Sodium (MELD-Na) and AARC scores on admission averaged 32 ± 6 and 10.4 ± 1.9. At 90 days, 51% survived. Nonviral precipitant, diabetes, bilirubin, international normalized ratio, and encephalopathy were independent factors influencing mortality. Adding diabetes and precipitant to MELD-Na and AARC scores, the novel MAFLD-MELD-Na score (+12 for diabetes, +12 for nonviral precipitant), and MAFLD-AARC score (+5 for each) were formed. These outperformed the standard scores in both cohorts. DISCUSSION: Almost half of patients with MAFLD-ACLF die within 90 days. Diabetes and nonviral precipitants such as drug-induced liver injury and sepsis lead to adverse outcomes. The new MAFLD-MELD-Na and MAFLD-AARC scores provide reliable 90-day mortality predictions for patients with MAFLD-ACLF.
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S105
Endoscopic Ampullectomy with Endo-pancreatic Radio-frequency Ablation for an Ampullary Adenoma with Pancreatic Dutal Extension
Text A 60 years old male with prior decompensated cirrhosis due to ethanol presented with new onset obstructive jaundice and cholangitis. Imaging showed bile duct obstruction at its lower end. Endoscopic ultrasound showed ampullary mass. ERCP with CBD stenting with ampullary biopsy was done. Histopathology showed tubular adenoma. Endoscopic ampullectomy was performed. Post-procedure pancreatogram showed pancreatic ductal extension. This was confirmed by pancreatoscopy. Endoscopic radio-frequency ablation was performed, and follow-up pancreatoscopy three months later showed no ampullary mass or intra-ductal lesion. The patient was asymptomatic. There was no decompensation of liver diease [1]. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S105
Endoscopic Ampullectomy with Endo-pancreatic Radio-frequency Ablation for an Ampullary Adenoma with Pancreatic Dutal Extension
Text A 60 years old male with prior decompensated cirrhosis due to ethanol presented with new onset obstructive jaundice and cholangitis. Imaging showed bile duct obstruction at its lower end. Endoscopic ultrasound showed ampullary mass. ERCP with CBD stenting with ampullary biopsy was done. Histopathology showed tubular adenoma. Endoscopic ampullectomy was performed. Post-procedure pancreatogram showed pancreatic ductal extension. This was confirmed by pancreatoscopy. Endoscopic radio-frequency ablation was performed, and follow-up pancreatoscopy three months later showed no ampullary mass or intra-ductal lesion. The patient was asymptomatic. There was no decompensation of liver diease [1]. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 29 March 2023
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 14 (01) , 049-050
Endoscopic Management of a Complex Biliary Problem
Endoscopic interventions have become increasingly popular in the management of obstructive jaundice. In this case study, we present a case of complex Bismuth type 4 hilar stricture in an elderly lady presenting with obstructive jaundice. Complete endoscopic biliary drainage was accomplished successfully by placement of three metal stents – two with ERCP and one with Endoscopic Ultrasound (EUS) guided hepatico-gastrostomy. She developed cholecystitis later, which was successfully addressed by EUS guided gallbladder drainage using a cautery enhanced lumen apposing metal stent. Thus, a complete internal biliary drainage was achieved with endoscopic interventions.
- 29 March 2023
- Published by Georg Thieme Verlag KG in Journal of Digestive Endoscopy
- Vol. 14 (01) , 049-050
Open AccessEndoscopic Management of a Complex Biliary Problem
Endoscopic interventions have become increasingly popular in the management of obstructive jaundice. In this case study, we present a case of complex Bismuth type 4 hilar stricture in an elderly lady presenting with obstructive jaundice. Complete endoscopic biliary drainage was accomplished successfully by placement of three metal stents – two with ERCP and one with Endoscopic Ultrasound (EUS) guided hepatico-gastrostomy. She developed cholecystitis later, which was successfully addressed by EUS guided gallbladder drainage using a cautery enhanced lumen apposing metal stent. Thus, a complete internal biliary drainage was achieved with endoscopic interventions.
- Open Access
- 4 January 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 01) , E1114-E1115
Endoscopic resection of a large ampullary tumor using a hybrid endoscopic submucosal dissection and mucosal resection technique
A 52 year old man was referred with an ampullary lesion and a minor gastrointestinal (GI) bleed. Upper GI endoscopy showed an ulcerated ampullary mass ([Fig. 1]). Mucosal biopsy revealed an ampullary adenoma. Endoscopic submucosal dissection (ESD) was planned. First, endoscopic retrograde cholangiopancreatography (ERCP) with pancreatic duct stenting was performed ([Video 1]). Markings were made at the proximal part of the lesion. A submucosal injection of methylene blue was performed, followed by mucosal incision using a J-knife. After the lesion had been partially dissected by ESD, multiple large feeding vessels were encountered in the submucosal space ([Fig. 2 a]). Achievement of hemostasis was difficult and the endoscopic field was repeatedly compromised ([Fig. 2 b]). We therefore switched to the endoscopic mucosal resection (EMR) technique. A 30-mm snare was advanced over the mass ([Fig. 2 c]). After 1 minute of alternating coagulation (forced coagulation, effect 4.5) and cutting (Endocut Q, effect 3) current, the mass, which measured 4 cm in length ([Fig. 2 d]), was completely resected. New plastic stents were placed in the pancreatic and bile ducts, and the patient recovered uneventfully. Video 1 A vascular ampullary mass with large bleeding submucosal vessels that precluded complete resection by endoscopic submucosal dissection (ESD) is removed with a hybrid ESD and endoscopic mucosal resection (EMR) procedure. Histopathology of the resected specimen showed a neuroendocrine tumor (NET) ([Fig. 3]). A positron emission tomography (PET) scan showed no residual lesion or metastasis. The patient was asymptomatic at 9 months after the resection. Duodenoscopy showed no recurrence ([Fig. 4]) and repeat ampullary biopsies showed no residual tumor. Duodenal ESD is deemed risky for lesions larger than 2 cm [1] [2]; however, it is safe and effective in experienced hands. Here, we describe a novel hybrid ESD–EMR technique for a large vascular ampullary lesion. To our knowledge, this is the first case of an ampullary lesion resected using this combined technique. This may be useful for vascular subepithelial lesions such as NETs or those with submucosal fibrosis, where submucosal dissection cannot be completed owing to safety or visibility issues. Endoscopy_UCTN_Code_TTT_1AO_2AC Article published online: 06 October 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 4 January 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 01) , E1114-E1115
Open AccessEndoscopic resection of a large ampullary tumor using a hybrid endoscopic submucosal dissection and mucosal resection technique
A 52 year old man was referred with an ampullary lesion and a minor gastrointestinal (GI) bleed. Upper GI endoscopy showed an ulcerated ampullary mass ([Fig. 1]). Mucosal biopsy revealed an ampullary adenoma. Endoscopic submucosal dissection (ESD) was planned. First, endoscopic retrograde cholangiopancreatography (ERCP) with pancreatic duct stenting was performed ([Video 1]). Markings were made at the proximal part of the lesion. A submucosal injection of methylene blue was performed, followed by mucosal incision using a J-knife. After the lesion had been partially dissected by ESD, multiple large feeding vessels were encountered in the submucosal space ([Fig. 2 a]). Achievement of hemostasis was difficult and the endoscopic field was repeatedly compromised ([Fig. 2 b]). We therefore switched to the endoscopic mucosal resection (EMR) technique. A 30-mm snare was advanced over the mass ([Fig. 2 c]). After 1 minute of alternating coagulation (forced coagulation, effect 4.5) and cutting (Endocut Q, effect 3) current, the mass, which measured 4 cm in length ([Fig. 2 d]), was completely resected. New plastic stents were placed in the pancreatic and bile ducts, and the patient recovered uneventfully. Video 1 A vascular ampullary mass with large bleeding submucosal vessels that precluded complete resection by endoscopic submucosal dissection (ESD) is removed with a hybrid ESD and endoscopic mucosal resection (EMR) procedure. Histopathology of the resected specimen showed a neuroendocrine tumor (NET) ([Fig. 3]). A positron emission tomography (PET) scan showed no residual lesion or metastasis. The patient was asymptomatic at 9 months after the resection. Duodenoscopy showed no recurrence ([Fig. 4]) and repeat ampullary biopsies showed no residual tumor. Duodenal ESD is deemed risky for lesions larger than 2 cm [1] [2]; however, it is safe and effective in experienced hands. Here, we describe a novel hybrid ESD–EMR technique for a large vascular ampullary lesion. To our knowledge, this is the first case of an ampullary lesion resected using this combined technique. This may be useful for vascular subepithelial lesions such as NETs or those with submucosal fibrosis, where submucosal dissection cannot be completed owing to safety or visibility issues. Endoscopy_UCTN_Code_TTT_1AO_2AC Article published online: 06 October 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany